BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10207094)

  • 21. A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality.
    Son SH; Kim MY; Choi S; Kim JS; Lee YS; Lee S; Lee YJ; Lee JY; Lee SE; Lim YS; Ha DH; Oh E; Won YB; Ji CJ; Park MA; Kim B; Byun KT; Chung MS; Jeong J; Choi D; Baek EJ; Cho EH; Kim SB; Je AR; Kweon HS; Park HS; Park D; Bae JS; Jang SJ; Yun CO; Chae JH; Lee JW; Lee SJ; Kim CG; Kang HC; Uversky VN; Kim CG
    Adv Sci (Weinh); 2023 Nov; 10(33):e2305096. PubMed ID: 37845006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Hill type equation can predict target gene expression driven by p53 pulsing.
    Shi X
    FEBS Open Bio; 2021 Jun; 11(6):1799-1808. PubMed ID: 33955710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein neddylation and its role in health and diseases.
    Zhang S; Yu Q; Li Z; Zhao Y; Sun Y
    Signal Transduct Target Ther; 2024 Apr; 9(1):85. PubMed ID: 38575611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.
    Jo SY; Hong N; Lee S; Jeong JJ; Won J; Park J; Kim GJ; Kim SK; Kim S; Rhee Y
    Exp Mol Med; 2023 May; 55(5):886-897. PubMed ID: 37121965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathway-based approach reveals differential sensitivity to E2F1 inhibition in glioblastoma.
    Alvarado AG; Tessema K; Muthukrishnan SD; Sober M; Kawaguchi R; Laks DR; Bhaduri A; Swarup V; Nathanson DA; Geschwind DH; Goldman SA; Kornblum HI
    Cancer Res Commun; 2022 Sep; 2(9):1049-1060. PubMed ID: 36213002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzo[a]pyrene represses DNA repair through altered E2F1/E2F4 function marking an early event in DNA damage-induced cellular senescence.
    Allmann S; Mayer L; Olma J; Kaina B; Hofmann TG; Tomicic MT; Christmann M
    Nucleic Acids Res; 2020 Dec; 48(21):12085-12101. PubMed ID: 33166399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDM2's dual mRNA binding domains co-ordinate its oncogenic and tumour suppressor activities.
    Gnanasundram SV; Malbert-Colas L; Chen S; Fusée L; Daskalogianni C; Muller P; Salomao N; Fåhraeus R
    Nucleic Acids Res; 2020 Jul; 48(12):6775-6787. PubMed ID: 32453417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning of Hynobius lichenatus (Tohoku hynobiid salamander) p53 and analysis of its expression in response to radiation.
    Kamada T; Une Y; Matsui K; Fuma S; Ikeda T; Okamoto M
    BMC Genet; 2020 May; 21(1):53. PubMed ID: 32434469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells.
    Islam MS; Takano R; Yokochi T; Akter J; Nakamura Y; Nakagawara A; Tatsumi Y
    BMC Cancer; 2019 Jun; 19(1):542. PubMed ID: 31170959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin.
    Habtemariam S; Lentini G
    Biomedicines; 2018 Mar; 6(2):. PubMed ID: 29587429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer.
    Di Sante G; Di Rocco A; Pupo C; Casimiro MC; Pestell RG
    Oncotarget; 2017 Oct; 8(47):81803-81812. PubMed ID: 29137223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Evolution of the Ribosomal Protein-MDM2-p53 Pathway.
    Deisenroth C; Franklin DA; Zhang Y
    Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27908926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.
    Cataldo A; Cheung DG; Balsari A; Tagliabue E; Coppola V; Iorio MV; Palmieri D; Croce CM
    Oncotarget; 2016 Jan; 7(1):786-97. PubMed ID: 26623722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2F2 induction in related to cell proliferation and poor prognosis in non-small cell lung carcinoma.
    Chen L; Yu JH; Lu ZH; Zhang W
    Int J Clin Exp Pathol; 2015; 8(9):10545-54. PubMed ID: 26617764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2.
    Ozaki T; Nakamura M; Shimozato O
    Biomolecules; 2015 Oct; 5(4):2854-76. PubMed ID: 26512706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells.
    Castillo DS; Campalans A; Belluscio LM; Carcagno AL; Radicella JP; Cánepa ET; Pregi N
    Cell Cycle; 2015; 14(8):1300-14. PubMed ID: 25892555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2F1 responds to ultraviolet radiation by directly stimulating DNA repair and suppressing carcinogenesis.
    Biswas AK; Mitchell DL; Johnson DG
    Cancer Res; 2014 Jun; 74(12):3369-77. PubMed ID: 24741006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F1-mediated DNA damage is implicated in 8-Cl-adenosine-induced chromosome missegregation and apoptosis in human lung cancer H1299 cells.
    Han YY; Zhou Z; Cao JX; Jin YQ; Li SY; Ni JH; An GS; Zhang YX; Jia HT
    Mol Cell Biochem; 2013 Dec; 384(1-2):187-96. PubMed ID: 24037421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA repair initiation induces expression of ribonucleotide reductase in human chronic lymphocytic leukemia cells.
    Sandoval MR; Balakrishnan K; Luthra R; Keating M; Gandhi V
    Leuk Lymphoma; 2014 Apr; 55(4):876-83. PubMed ID: 23772636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rbf1 degron dysfunction enhances cellular DNA replication.
    Raj N; Zhang L; Wei Y; Arnosti DN; Henry RW
    Cell Cycle; 2012 Oct; 11(20):3731-8. PubMed ID: 22895052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.